These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 37692959)
1. Agomelatine enhances the therapeutic effect of venlafaxine on depression and improves the levels of S100B and GFAP. Zheng J; Zhao Q; Ma Y; Tian J; Sun L; Zhang Z; Guo L Am J Transl Res; 2023; 15(8):5528-5535. PubMed ID: 37692959 [TBL] [Abstract][Full Text] [Related]
2. Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression. Michel M; Fiebich BL; Kuzior H; Meixensberger S; Berger B; Maier S; Nickel K; Runge K; Denzel D; Pankratz B; Schiele MA; Domschke K; van Elst LT; Endres D Transl Psychiatry; 2021 May; 11(1):308. PubMed ID: 34021122 [TBL] [Abstract][Full Text] [Related]
3. Glial Fibrillary Acidic Protein (GFAP) Outperforms S100 Calcium-Binding Protein B (S100B) and Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) as Predictor for Positive Computed Tomography of the Head in Trauma Subjects. Mahan MY; Thorpe M; Ahmadi A; Abdallah T; Casey H; Sturtevant D; Judge-Yoakam S; Hoover C; Rafter D; Miner J; Richardson C; Samadani U World Neurosurg; 2019 Aug; 128():e434-e444. PubMed ID: 31051301 [TBL] [Abstract][Full Text] [Related]
4. Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations. Petzold A; Eikelenboom MJ; Gveric D; Keir G; Chapman M; Lazeron RH; Cuzner ML; Polman CH; Uitdehaag BM; Thompson EJ; Giovannoni G Brain; 2002 Jul; 125(Pt 7):1462-73. PubMed ID: 12076997 [TBL] [Abstract][Full Text] [Related]
5. CSF-S100B Is a Potential Candidate Biomarker for Neuromyelitis Optica Spectrum Disorders. Wei Y; Chang H; Li X; Du L; Xu W; Cong H; Yao Y; Zhang X; Yin L Biomed Res Int; 2018; 2018():5381239. PubMed ID: 30426010 [TBL] [Abstract][Full Text] [Related]
6. Biochemical markers of cerebrospinal ischemia after repair of aneurysms of the descending and thoracoabdominal aorta. Anderson RE; Winnerkvist A; Hansson LO; Nilsson O; Rosengren L; Settergren G; Vaage J J Cardiothorac Vasc Anesth; 2003 Oct; 17(5):598-603. PubMed ID: 14579213 [TBL] [Abstract][Full Text] [Related]
7. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Vos PE; Lamers KJ; Hendriks JC; van Haaren M; Beems T; Zimmerman C; van Geel W; de Reus H; Biert J; Verbeek MM Neurology; 2004 Apr; 62(8):1303-10. PubMed ID: 15111666 [TBL] [Abstract][Full Text] [Related]
8. Venlafaxine ameliorates the depression-like behaviors and hippocampal S100B expression in a rat depression model. Wang CH; Gu JY; Zhang XL; Dong J; Yang J; Zhang YL; Ning QF; Shan XW; Li Y Behav Brain Funct; 2016 Dec; 12(1):34. PubMed ID: 27931233 [TBL] [Abstract][Full Text] [Related]
9. Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine. Lemoine P; Guilleminault C; Alvarez E J Clin Psychiatry; 2007 Nov; 68(11):1723-32. PubMed ID: 18052566 [TBL] [Abstract][Full Text] [Related]
10. Plasma biomarkers of brain injury in COVID-19 patients with neurological symptoms. Sahin BE; Celikbilek A; Kocak Y; Saltoglu GT; Konar NM; Hizmali L J Neurol Sci; 2022 Aug; 439():120324. PubMed ID: 35752131 [TBL] [Abstract][Full Text] [Related]
11. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury. Böhmer AE; Oses JP; Schmidt AP; Perón CS; Krebs CL; Oppitz PP; D'Avila TT; Souza DO; Portela LV; Stefani MA Neurosurgery; 2011 Jun; 68(6):1624-30; discussion 1630-1. PubMed ID: 21368691 [TBL] [Abstract][Full Text] [Related]
12. NRGN, S100B and GFAP levels are significantly increased in patients with structural lesions resulting from mild traumatic brain injuries. Çevik S; Özgenç MM; Güneyk A; Evran Ş; Akkaya E; Çalış F; Katar S; Soyalp C; Hanımoğlu H; Kaynar MY Clin Neurol Neurosurg; 2019 Aug; 183():105380. PubMed ID: 31234132 [TBL] [Abstract][Full Text] [Related]
13. Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients. Brouns R; De Vil B; Cras P; De Surgeloose D; Mariën P; De Deyn PP Clin Chem; 2010 Mar; 56(3):451-8. PubMed ID: 19959621 [TBL] [Abstract][Full Text] [Related]
14. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. Pelinka LE; Kroepfl A; Leixnering M; Buchinger W; Raabe A; Redl H J Neurotrauma; 2004 Nov; 21(11):1553-61. PubMed ID: 15684648 [TBL] [Abstract][Full Text] [Related]
15. Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders. Schulz I; Kruse N; Gera RG; Kremer T; Cedarbaum J; Barbour R; Zago W; Schade S; Otte B; Bartl M; Hutten SJ; Trenkwalder C; Mollenhauer B Mov Disord; 2021 Dec; 36(12):2874-2887. PubMed ID: 34363416 [TBL] [Abstract][Full Text] [Related]
16. The role of S100B protein, neuron-specific enolase, and glial fibrillary acidic protein in the evaluation of hypoxic brain injury in acute carbon monoxide poisoning. Akdemir HU; Yardan T; Kati C; Duran L; Alacam H; Yavuz Y; Okuyucu A Hum Exp Toxicol; 2014 Nov; 33(11):1113-20. PubMed ID: 24505052 [TBL] [Abstract][Full Text] [Related]
17. Astroglial Mechanisms Underlying Chronic Insomnia Disorder: A Clinical Study. Zhang P; Li YX; Zhang ZZ; Yang Y; Rao JX; Xia L; Li XY; Chen GH; Wang F Nat Sci Sleep; 2020; 12():693-704. PubMed ID: 33117005 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study - "the PreTBI I study". Seidenfaden SC; Kjerulff JL; Juul N; Kirkegaard H; Møller MF; Münster AB; Bøtker MT Scand J Trauma Resusc Emerg Med; 2021 Jun; 29(1):75. PubMed ID: 34078435 [TBL] [Abstract][Full Text] [Related]
19. Effects of hypothermia on S100B and glial fibrillary acidic protein in asphyxia rats after cardiopulmonary resuscitation. Liu S; Zhang Y; Zhao Y; Cui H; Cao C; Guo J Cell Biochem Biophys; 2015 Jan; 71(1):401-6. PubMed ID: 25209741 [TBL] [Abstract][Full Text] [Related]
20. EPO treatment does not alter acute serum profiles of GFAP and S100B after TBI: A brief report on the Australian EPO-TBI clinical trial. Hellewell SC; Conquest A; Little L; Vallance S; Board J; Bellomo R; Cooper DJ; Morganti-Kossmann MC J Clin Neurosci; 2020 Jun; 76():5-8. PubMed ID: 32331937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]